Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine analysts that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1-year target […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has earned an average rating of “Moderate Buy” from the nine research firms that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month target […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) shares reached a new 52-week low on Tuesday . The company traded as low as $26.57 and last traded at $26.73, with a volume of 291079 shares traded. The stock had previously closed at $27.67. Analyst Upgrades and Downgrades A number of research firms have issued reports […]
Piper Sandler Lowers Pacira BioSciences (NASDAQ:PCRX) Price Target to $42 00 kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Pacira BioSciences (NASDAQ:PCRX – Get Free Report) is set to release its earnings data before the market opens on Thursday, November 2nd. Analysts expect Pacira BioSciences to post earnings of $0.84 per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link. Pacira BioSciences […]